Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. [electronic resource]
Producer: 20011204Description: 2280-8 p. digitalISSN:- 1524-4539
- Aged
- Alzheimer Disease -- drug therapy
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Arthritis, Rheumatoid -- drug therapy
- Cardiovascular Diseases -- epidemiology
- Chronic Disease
- Clinical Trials, Phase II as Topic -- statistics & numerical data
- Clinical Trials, Phase III as Topic -- statistics & numerical data
- Clinical Trials, Phase IV as Topic -- statistics & numerical data
- Comorbidity
- Cyclooxygenase 1
- Cyclooxygenase 2
- Female
- Humans
- Isoenzymes -- antagonists & inhibitors
- Lactones -- adverse effects
- Low Back Pain -- drug therapy
- Male
- Membrane Proteins
- Middle Aged
- Naproxen -- adverse effects
- Osteoarthritis -- drug therapy
- Proportional Hazards Models
- Prostaglandin-Endoperoxide Synthases
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Risk
- Sulfones
- Thrombosis -- epidemiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.